SCHEMBL3758965

SCHEMBL3758965

CC1(C)Cc2c(sc(N3CCOCC3)c2C(=O)NC(c2ccccc2)c2ccccn2)C(=O)N1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 3/20 0.43
CNR1 P21554 2/20 0.43
PIK3CA P42336 3/20 0.38
PIK3CD O00329 2/20 0.38
PIK3CB P42338 2/20 0.38
PIK3CG P48736 2/20 0.38
KCNK3 O14649 1/20 0.38
S1PR2 O95136 1/20 0.37
S1PR4 O95977 1/20 0.37
S1PR3 Q99500 1/20 0.37
ALDH1A1 P00352 2/20 0.37
DRD2 P14416 1/20 0.35
NR1H4 Q96RI1 1/20 0.34
MAPK1 P28482 4/20 0.34
HTT P42858 1/20 0.34
HIF1A Q16665 1/20 0.34
IRAK4 Q9NWZ3 1/20 0.34
PIK3R1 P27986 1/20 0.33
KDM4E B2RXH2 1/20 0.33
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3762615 0.87 CNR2 (0.42) CNR2CNR1PIK3CAPIK3CDPIK3CB
SCHEMBL3764745 0.75 PIK3CD (0.52) PIK3CAPIK3CDPIK3CBPIK3CGALDH1A1
SCHEMBL3759473 0.73 PIK3CD (0.52) PIK3CAPIK3CDPIK3CBPIK3CGALDH1A1
SCHEMBL3766781 0.70 PIK3CD (0.45) PIK3CAPIK3CDPIK3CBPIK3CGHTT
SCHEMBL3760314 0.69 PIK3CD (0.42) PIK3CAPIK3CDPIK3CBPIK3CGALDH1A1
SCHEMBL3755397 0.68 PIK3CA (0.47) PIK3CAPIK3CDPIK3CBPIK3CGALDH1A1
SCHEMBL3759213 0.67 PIK3CA (0.46) PIK3CAPIK3CDPIK3CBPIK3CGALDH1A1
SCHEMBL3760006 0.67 PRKDC (0.39) PIK3CAPIK3CDPIK3CBPIK3CGALDH1A1
SCHEMBL3763208 0.67 PIK3CD (0.45) PIK3CAPIK3CDPIK3CBPIK3CGALDH1A1
SCHEMBL3763214 0.67 PIK3CD (0.45) PIK3CAPIK3CDPIK3CBPIK3CGALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2029570-B1 FUSED THIOPHENE DERIVATIVES AS KINASE INHIBITORS UCB PHARMA SA (BE) 2014-10-15 EP disclosed
US-8324204-B2 Fused thiophene derivatives as kinase inhibitors UCB PHARMA SA (BE) 2012-12-04 US disclosed
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors UCB PHARMA S.A. (BE) 2010-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors PIKFYVE, PI4KA, PIK3CA CNR2 3147/4885CNR1 4238/4885PIK3CA 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.